Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:O14944 (
EPR
)
13,097
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Crystal structure of bis[cinchoninium tetrachlorocuprate(II)] trihydrate, [(
C19H24N2O
)CuCl4]2-3H2O, has been determined by X-ray diffraction at 100 K and reexamined at 293 K. The compound crystallizes in orthorhombic system with a P2(1)2(1)2(1) space group and unit cell parameters a = 15.3031(14), b = 36.415(3), and c = 7.8341(5) A at 100 K, and Z = 4. The asymmetric unit consists of two (CuCl4)(2-) tetrahedral anions linked by hydrogen bonds to two doubly protonated cinchonine molecules and three water molecules. The tetrahedra are strongly flattened, to approximately D(2d) symmetry, with different deformation for two inequivalent (CuCl4)(2-) -ions in the asymmetric unit. The deformation of (CuCl4)(2-) and cinchoninium cations varies with temperature due to a rearrangement of the bifurcated hydrogen bond network. This is a continuous process observed as a monotonic variation of the
EPR
spectral parameters and the unit cell dimensions.
EPR
spectra show that very weak exchange coupling J(12) = 0.0030 cm(-1) operates between Cu(2+) ions within asymmetric units, corresponding to the general formula of the compound, as well as between equivalent Cu(2+) sites of different molecules, whereas the coupling is negligible between inequivalent sites. The intermolecular J(12) coupling is temperature-independent indicating that the whole asymmetric unit behaves as a magnetic unit (pseudodimer) in the whole temperature range.
...
PMID:Flexibility of CuCl4-tetrahedra in bis[cinchoninium tetrachlorocuprate(II)]trihydrate single crystals. X-ray diffraction and EPR studies. 1151 Nov 95